Highbridge Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Highbridge Capital Management’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,333,552	Closed	-$92.3M	–	479
2023 Q1	$92.3M	Hold	6,333,552	–	–	3.4%	2
2022 Q4	$46.2M	Hold	6,333,552	–	–	1.27%	9
2022 Q3	$43.8M	Hold	6,333,552	–	–	0.62%	13
2022 Q2	$44.3M	Buy	6,333,552 +273,552	+5%	+$2.13M	1.01%	7
2022 Q1	$50.1M	Buy	6,060,000 +4,198,474	+226%	+$37.9M	1.16%	9
2021 Q4	$20.1M	Buy	1,861,526 +227,160	+14%	+$2.45M	0.44%	50
2021 Q3	$19.8M	Buy	1,634,366 +960,965	+143%	+$10.8M	0.52%	59
2021 Q2	$8.17M	Sell	673,401 -339,023	-33%	-$4.21M	0.23%	121
2021 Q1	$14.1M	Buy	1,012,424 +185,994	+23%	+$2.6M	0.56%	49
2020 Q4	$11.7M	Buy	826,430 +150,396	+22%	+$1.96M	0.45%	64
2020 Q3	$8.28M	Buy	+676,034	New	+$7.83M	0.45%	55

Highbridge Capital Management's AMYT Position: Q2 2023 in Review

Highbridge Capital Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 6,333,552 shares — an estimated $92.3M sold.

Highbridge Capital Management first reported a position in AMYT in Q3 2020 and held it in 11 quarters. The position peaked at $92.3M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Highbridge Capital Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Highbridge Capital Management sold 6,333,552 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $92.3M.
Highbridge Capital Management first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 11 quarters.
Highbridge Capital Management's Amryt Pharma plc American Depositary Shares position peaked at $92.3M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Highbridge Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.